Clinical trial
A Comparative Bioavailability Study of Naproxen Delayed-Release Tablets, 375mg.
NCT00959439 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparative Bioavailability Study of Naproxen Delayed-Release Tablets, 375mg.
- Lead sponsor
- Sandoz
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 31, 2002
- Completion date
- May 31, 2002
- Enrollment
- 34 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
osteoarthritis, rheumatoid arthritis